Margot Baker et al v. McKesson Corporation et al

Filing 30

ORDER TRANSFERRING CASE to the USDC-Southern District of New York. (hdjS, COURT STAFF) (Filed on 2/22/2017)

Case MDL No. 2754 Document 89 Filed 02/15/17 Page 1 of 2

UNITED STATES JUDICIAL PANEL
on

MULTIDISTRICT LITIGATION

IN RE: ELIQUIS (APIXABAN) PRODUCTS
LIABILITY LITIGATION

MDL No. 2754

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO -1)

On February 7, 2017, the Panel transferred 18 civil action(s) to the United States District Court for
the Southern District of New York for coordinated or consolidated pretrial proceedings pursuant to
28 U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2017). Since that time, no additional action(s) have
been transferred to the Southern District of New York. With the consent of that court, all such
actions have been assigned to the Honorable Denise L Cote.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Southern District of New York and assigned to
Judge Cote.
Pursuant to Rule 7.1 ofthe Rules ofProcedure ofthe United States Judicial Panel on Multidistrict
Liti~ation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Southern District of New York for the reasons stated in the order of February 7, 2017, and, with the
consent of that court, assigned to the Honorable Denise L Cote.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Southern District ofNew York. The transmittal of this order to said Clerk shall
be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7-day period, the stay will be continued until further order of the Panel.
Inasmuch as no objection is
pending at this time, the
stay is lifted.

I Feb 15, 20171
CLERK'S OFFICE
UNITED STATES
JUDICIAL PANEL ON
MULTIDISTRICT LITIGATION

FOR THE PANEL:

~
Jeffery N. Li.ithi
Clerk of the Panel

A CERTIFIED COPY
RUBY. J. K.RAJICK, CLERK

BY~~w
Depu

Clerk

Case MDL No. 2754 Document 89 Filed 02/15/17 Page 2 of 2

IN RE: ELIQUIS (APIXABAN) PRODUCTS
LIABILITY LITIGATION

MDL No. 2754

SCHEDULE CT0-1- TAG-ALONG ACTIONS

C.A.NO.

CASE CAPTION

16-00802

Bowers v. Bristol-Myers Squibb Company et al

ARIZONA
AZ

4

CALIFORNIA CENTRAL
GAb
GAb
GAb
GAb
GAb
GAb
GAb
GAb
GAb

16
16
16
16
16

98ll§
981;;!4
98LB
98tH
99§16

~

r7

99~§4

~

16 g;;;;;;gg
16 9;;!6;;!1
16 91988

~
~
~

~
~

~

%

Or:ra Lebastehi v. McKesson Corporation et al Opposed 2114/17
Gabriel Dellutri v. McKesson Corporation et al Opposed 2/14/17
Dolores \Villiam:s v. McKesson Corporation et alOpposed 2/14/17
Mariano Aguirre et al v. McKesson Corporation et al opposed 2/14/17
John Barsky et al ¥.McKesson Corporation et al Opposed 2/14/17
Johnny Jackson et al v. McKesson Corporation et al opposed 2/14/17
Judy Hayes v. McKesson Corporation et al
Opposed 2/14/17
Vlilliam Altare et al v. McKesson Corporation et al opposed 21 14117
Nanna Stuart v. McKesson Corporation et al
Opposed 2/14/17

CALIFORNIA EASTERN

17 9999§

Stark et al v. McKesson Corporation et al

Opposed 2/14/17

CALIFORNIA NORTHERN
CAN

3

17-00074

Margot Baker et al v. McKesson Corporation et al

CALIFORNIA SOUTHERN
Opposed 2/14/17

16 92711
16 92719

Quarg v. McKesson Corporation et al
Fonger et al v. McKesson Corporation et al

16-15940
17-00543

Walker, et al v. Bristol-Myers Squibb Company, et al
Tudela v. Bristol-Myers Squibb, et al

Opposed 2/14/17

LOUISIANA EASTERN
LAE
LAE

2
2